Evidence map›Paper›PMID 35455484›Full record

ReviewPharmaceuticals (Basel, Switzerland)2022

Photodynamic Anti-Bacteria by Carbon Dots and Their Nano-Composites.

Xiaoyan Wu, Khurram Abbas, Yuxiang Yang, Zijian Li, Antonio Claudio Tedesco, Hong Bi

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review of Antimicrobial Properties of Carbon Nanomaterials.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Carbon Dots in Photodynamic/Photothermal Antimicrobial Therapy.Nanomaterials (Basel, Switzerland) · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Xiaoyan WuSchool of Chemistry and Chemical Engineering, Anhui University, Hefei 230601, China.
Khurram AbbasSchool of Chemistry and Chemical Engineering, Anhui University, Hefei 230601, China.
Yuxiang YangSchool of Chemistry and Chemical Engineering, Anhui University, Hefei 230601, China.
Zijian LiSchool of Materials Science and Engineering, Anhui University, Hefei 230601, China.
Antonio Claudio TedescoSchool of Chemistry and Chemical Engineering, Anhui University, Hefei 230601, China.ORCID 0000-0003-4198-9321
Hong BiSchool of Chemistry and Chemical Engineering, Anhui University, Hefei 230601, China.ORCID 0000-0003-3929-4491
Anhui University · CN

Funding

National Natural Science Foundation of China 51772001National Natural Science Foundation of China 52172033the Anhui Province Key Research and Development Plan Project International Science and Technology Cooperation Special Project 202004b11020015
6 · The paper itself

Abstract

The misuse of many types of broad-spectrum antibiotics leads to increased antimicrobial resistance. As a result, the development of a novel antibacterial agent is essential. Photodynamic antimicrobial chemotherapy (PACT) is becoming more popular due to its advantages in eliminating drug-resistant strains and providing broad-spectrum antibacterial resistance. Carbon dots (CDs), zero-dimensional nanomaterials with diameters smaller than 10 nm, offer a green and cost-effective alternative to PACT photosensitizers. This article reviewed the synthesis methods of antibacterial CDs as well as the recent progress of CDs and their nanocomposites in photodynamic sterilization, focusing on maximizing the bactericidal impact of CDs photosensitizers. This review establishes the base for future CDs development in the PACT field.

Indexed as

antimicrobialcarbon dotslight activationphotodynamic effectreactive oxygen species

Identifiers

PMID35455484
PMCPMC9032997
OpenAlexW4224230364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.